Fresh analysis suggests that patients who discontinue blockbuster slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who stop traditional lifestyle plans.
Published data in a major health publication shows that while obese people often shed substantial amounts of their body weight while on the medication, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"Individuals using such treatments need to be aware of the potential of quick weight regain when the therapy ends," stated lead investigator Dr. Susan Jebb.
This pace of recovery means a return to original weight in about one and a half years.
Weighing Therapies
The research, which examined 37 of studies involving thousands of patients, contrasted the results of the injectable medications with older methods.
Scientists point out that people who shed pounds through lifestyle changes alone typically have a more gradual weight regain—approximately 0.1 kg a month—post-intervention.
The Reason for the Fast Rebound
Doctors propose the mechanism of the drugs accounts for the amplified weight return.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 levels several times higher than the body's typical production might result in the system to produce less of its endogenous GLP-1, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement leads to appetite is unsuppressed, making overeating far more likely."
A Lifelong Issue?
Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
Many experts say that, given the likelihood of weight regain, the treatment might need to be life-long.
This opinion is reinforced by pharmaceutical companies, who say that the results "underscore the long-term character of obesity," comparing it to managing conditions like high blood pressure.
User Experiences
Users who have discontinued the medication explain a powerful return of hunger.
"It felt as if a switch activating and you're instantly extremely hungry," said a patient.
This challenge is worsened if patients have not developed sustainable lifestyle or habit modifications during treatment.
Significant Adoption
Survey data indicate that a significant number of people in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Adoption is greater among females compared to males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the medications through private healthcare rather than the NHS.
In conclusion, researchers stress that while these medications are potent agents for weight loss, they are not a permanent fix and long-term success likely depends on combined behavioural support.
